Healthcare -
Biotechnology - NASDAQ - GB
$ 10.505
-2.19 %
$ 7.5 B
Market Cap
-10.5
P/E
ROIV - INTEREST INCOME & EXPENSE
Interest Income & Expense ROIV - Roivant Sciences Ltd.
34.8 M
LAST VALUE
122.25%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR